Search results
Moderna announces positive Phase III data for Covid-19/Influenza mRNA vaccine
Clinical Trials Arena via Yahoo Finance· 2 days agoAt this time, mRNA-1083 is poised to be the first Covid-19/influenza combination vaccine and the...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 3 days agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...
COVID Variant KP.3 Surges to Dominance—Here's What You Need to Know
Health via Yahoo News· 17 hours agoThe CDC reported last week that COVID-19 infections are “growing or likely growing in 30 states and...
Moderna says new-generation COVID vaccine more effective than Spikevax
Market Watch· 21 hours agosaid Thursday a Phase 3 trial of its next-generation COVID-19 vaccine met its main goal and showed...
Former GB News presenter says Ofcom killed his career over Covid vaccine claims
Daily Telegraph· 3 days agoMark Steyn, the former GB News presenter, has accused Ofcom of “killing his career” after he...
Combined flu and Covid vaccine from Moderna shows positive results
dpa international via Yahoo News· 4 days agoThe results raise hopes the new vaccine could be approved by regulators this year, with the...
Moderna sees positive results in COVID-flu vaccine trial
The Hill via AOL· 4 days agoModerna’s late-stage trial for its COVID-flu combination vaccine yielded positive results, the...
Past COVID infections may help protect against certain colds. Could it lead to better vaccines?
Medical Xpress· 2 days agoA new study suggests previous COVID-19 infections lower the risk of getting colds caused by milder...
COVID cases rising in L.A. County and California as new subvariants make mark
LA Times via Yahoo News· 2 days agoOne report published in March by the CDC, which looked at adults with immunocompromising conditions,...
Combo COVID/flu vaccine elicits higher immune response in trial
UPI· 4 days agoThe new vaccine contains components of mRNA-1010, Moderna's vaccine candidate for seasonal...